{"doc_id": "32876229", "type of study": "Therapy", "title": "", "abstract": "None\nCOVID-19 represents a global crisis.\nRapidly conducting a clinical trial with the rigor necessary to obtain reliable results requires the collaboration of various participants involved in the development, evaluation and authorization of clinical trials (CT) such as the trial sponsor, researchers, regulatory authority and the ethics committee (EC).\nCarrying out these studies is not only scientifically appropriate, but an ethical and moral obligation to guarantee our patients effective treatment.\nSOLIDARITY is a mega clinical trial that recruited thousands of subjects with moderate to severe disease, who were randomly assigned to one of the treatment groups under evaluation, including hydroxychloroquine, lopinavir/ritonavir associated or not with interferon; or remdesivir compared to standard therapy.\nPeru has joined the list of countries where the trial will be reproduced, through which it will be possible to quickly identify if any of these drugs offers a real benefit to patients.\n", "Evidence Map": {"Enrollment": [{"term": "moderate to severe disease", "negation": "affirmed", "UMLS": {}, "start": 78, "end": 104}], "Comparison Results": [], "Study Arm 1 Results": [], "Study Arm 2 Results": [], "Hypothesis": []}, "Sentence-level breakdown": [{"Section": "TITLE", "Text": "None", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "COVID-19 represents a global crisis .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Rapidly conducting a clinical trial with the rigor necessary to obtain reliable results requires the collaboration of various participants involved in the development , evaluation and authorization of clinical trials ( CT ) such as the trial sponsor , researchers , regulatory authority and the ethics committee ( EC ) .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Carrying out these studies is not only scientifically appropriate , but an ethical and moral obligation to guarantee our patients effective treatment .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "SOLIDARITY is a mega clinical trial that recruited thousands of subjects with moderate to severe disease , who were randomly assigned to one of the treatment groups under evaluation , including hydroxychloroquine , lopinavir / ritonavir associated or not with interferon ; or remdesivir compared to standard therapy .", "Evidence Elements": {"Participant": [{"term": "moderate to severe disease", "negation": "affirmed", "UMLS": {}, "start": 78, "end": 104}], "Intervention": [{"term": "hydroxychloroquine", "negation": "affirmed", "UMLS": {}, "start": 194, "end": 212}, {"term": "ritonavir associated or not with interferon", "negation": "affirmed", "UMLS": {}, "start": 227, "end": 270}, {"term": "remdesivir", "negation": "negated", "UMLS": {}, "start": 276, "end": 286}], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}, {"Section": "UNKNOWN", "Text": "Peru has joined the list of countries where the trial will be reproduced , through which it will be possible to quickly identify if any of these drugs offers a real benefit to patients .", "Evidence Elements": {"Participant": [], "Intervention": [], "Outcome": [], "Observation": [], "Count": []}, "Evidence Propositions": []}]}